Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Zhonghua Gan Zang Bing Za Zhi ; 24(8): 580-584, 2016 Aug 20.
Article in Chinese | MEDLINE | ID: mdl-27788704

ABSTRACT

Objective: To investigate the screening of serum biomarkers in patients with HBV-related acute-on-chronic liver failure (HBV-ACLF) by isobaric tags for relative and absolute quantitation (iTRAQ). Methods: Gel electrophoresis was used to isolate and remove high-abundant proteins. Each group of peptides was labeled by the iTRAQ reagents and then tested with an UltiMateTM 3000 nanoliter high-performance liquid chromatograph, and a Q-Exactive tandem mass spectrometer. The Protein Discovery software was used to analyze mass spectrometry data and perform bioinformatic analysis for differentially expressed proteins. Results: Ten samples each were included in the HBV-ACLF group and the chronic hepatitis B (CHB) group, and six samples each were included in the HBV-ACLF survival group and the HBV-ACLF death group. Compared with the CHB group, the HBV-ACLF group had 43 differentially expressed proteins, among which 34 were downregulated and 9 were upregulated. Compared with the HBV-ACLF survival group, the HBV-ACLF death group had 33 differentially expressed proteins, among which 18 were upregulated and 15 were downregulated. Conclusion: Keratin,α1-acid glycoprotein, and zinc-α2-glycoprotein identified in the serum may be used as potential biomarkers for predicting the prognosis of patients with HBV-ACLF.


Subject(s)
Acute-On-Chronic Liver Failure/blood , Biomarkers/blood , Hepatitis B, Chronic/blood , Adult , Down-Regulation , Electrophoresis, Agar Gel , Female , Glycoproteins/metabolism , Humans , Keratins/metabolism , Male , Middle Aged , Prognosis , Seminal Plasma Proteins/metabolism , Up-Regulation , Zn-Alpha-2-Glycoprotein
2.
Eur Rev Med Pharmacol Sci ; 20(18): 3839-3852, 2016 09.
Article in English | MEDLINE | ID: mdl-27735032

ABSTRACT

OBJECTIVE: Cerebral ischemia-reperfusion is the major pathophysiological process in stroke and can cause severe and lasting sequel. However, an intensive exercise training can potentially effect a quick and efficient recovery. We used swimming training on rats with cerebral ischemia-reperfusion (CIR) and explore the underlying neuroprotective mechanism(s), including the effects of intensive training on the expression of semaphorin 3A (Sema3A) and its receptor Neuropilin-1 (NRP-1). MATERIALS AND METHODS: The middle cerebral artery occlusion/reperfusion (MCAO/R) model was established by inserting a thread into the middle cerebral artery of Sprague-Dawley (SD) rats, and randomly dividing into the control group and training groups for different training intensities. The control group and the sham group received no training. All the rats in various groups were further randomly divided into three sub-groups for different postoperative time points (3, 7, and 14 days after operation). The apoptosis and the expression of Sema3A and NRP-1 were analyzed using immunohistochemistry (IHC), RT-PCR, and Western blotting methods respectively. RESULTS: The intensive training resulted in significant neurological function improvements at all the time points after MCAO, compared to that in the control group (p<0.05), with training group 3 (highest training intensity) showing the most remarkable recovery. The Sema3A and NP-1 expressions were significantly lower than those of the control group at all the time points (p<0.05), with training group 3 having the lowest levels (best recovery). CONCLUSIONS: Intensive training can reduce cerebral damage after ischemia and reperfusion in rats, inhibit the MCAO-induced Sema3A and NRP-1 expression, and accelerate the restoring process of motor nerve functions.


Subject(s)
Brain Ischemia/metabolism , Motor Skills , Physical Conditioning, Animal , Reperfusion Injury/therapy , Animals , Infarction, Middle Cerebral Artery , Rats , Rats, Sprague-Dawley , Recovery of Function , Reperfusion
SELECTION OF CITATIONS
SEARCH DETAIL
...